Roche Holding AG (RHHBF)

USD 303.32

(0.0%)

Long Term Debt Summary of Roche Holding AG

  • Roche Holding AG's latest annual long term debt in 2023 was 26.09 Billion CHF , up 17.09% from previous year.
  • Roche Holding AG's latest quarterly long term debt in 2024 Q1 was 30.15 Billion CHF , up 14.56% from previous quarter.
  • Roche Holding AG reported annual long term debt of 22.28 Billion CHF in 2022, up 30.3% from previous year.
  • Roche Holding AG reported annual long term debt of 17.1 Billion CHF in 2021, up 54.12% from previous year.
  • Roche Holding AG reported quarterly long term debt of 30.15 Billion CHF for 2024 Q1, up 14.56% from previous quarter.
  • Roche Holding AG reported quarterly long term debt of 20.34 Billion CHF for 2023 Q2, down -5.39% from previous quarter.

Annual Long Term Debt Chart of Roche Holding AG (2023 - 1998)

Historical Annual Long Term Debt of Roche Holding AG (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 26.09 Billion CHF 17.09%
2022 22.28 Billion CHF 30.3%
2021 17.1 Billion CHF 54.12%
2020 11.09 Billion CHF -18.09%
2019 13.54 Billion CHF -15.74%
2018 16.07 Billion CHF 1.5%
2017 15.83 Billion CHF -6.79%
2016 16.99 Billion CHF -0.63%
2015 17.1 Billion CHF -11.58%
2014 19.34 Billion CHF 17.77%
2013 16.42 Billion CHF -28.19%
2012 22.87 Billion CHF -2.51%
2011 23.45 Billion CHF -15.79%
2010 27.85 Billion CHF -22.93%
2009 36.14 Billion CHF 1116.12%
2008 2.97 Billion CHF -22.48%
2007 3.83 Billion CHF -38.15%
2006 6.19 Billion CHF -33.5%
2005 9.32 Billion CHF 34.19%
2004 6.94 Billion CHF -32.2%
2003 10.24 Billion CHF -27.68%
2002 14.16 Billion CHF -13.59%
2001 16.39 Billion CHF 1.41%
2000 16.16 Billion CHF 1.28%
1999 15.96 Billion CHF 14.6%
1998 13.92 Billion CHF 0.0%

Peer Long Term Debt Comparison of Roche Holding AG

Name Long Term Debt Long Term Debt Difference
AstraZeneca PLC 22.33 Billion USD -16.825%
Bristol-Myers Squibb Company PFD CONV 2 38.18 Billion USD 31.669%
CSPC Pharmaceutical Group Limited 107.05 Million USD -24270.902%
Clarus Therapeutics Holdings, Inc. - USD -Infinity%
Novartis AG 20.03 Billion USD -30.234%
PT Kalbe Farma Tbk. 19.39 Million USD -134445.895%